Ryan Martins
Finanzdirektor/CFO bei 89BIO, INC.
Vermögen: 879 524 $ am 30.04.2024
Profil
Ryan Stephen Martins is currently the Chief Financial Officer at 89bio, Inc. He previously worked as a Principal at Chiron Corp., an Associate at Lehman Brothers, Inc., a Vice President at Barclays Capital, Inc., a Senior Biotechnology Analyst at Jefferies LLC, and a Senior Biotechnology Analyst at FM Partners Holdings LLC.
Martins also served as the Chief Financial Officer at Revolution Medicines, Inc. for a brief period in 2018.
He earned his undergraduate degree from St. Xavier's College and completed his graduate studies at the University of Mumbai.
Martins also holds a graduate degree from Virginia Polytechnic Institute & State University and an MBA from the Haas School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
89BIO INC
0,11% | 17.02.2024 | 106 609 ( 0,11% ) | 879 524 $ | 30.04.2024 |
Aktive Positionen von Ryan Martins
Unternehmen | Position | Beginn |
---|---|---|
89BIO, INC. | Finanzdirektor/CFO | 01.07.2019 |
Ehemalige bekannte Positionen von Ryan Martins
Unternehmen | Position | Ende |
---|---|---|
REVOLUTION MEDICINES, INC. | Finanzdirektor/CFO | 01.10.2018 |
ULTRAGENYX PHARMACEUTICAL INC. | Investor Relations Kontakt | 01.03.2018 |
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Analyst-Equity | 01.07.2015 |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance FM Partners Holdings LLC is a broker/dealer headquartered in New York City. The firm was formerly known as Lazard Capital Markets LLC.. They are a subsidiary of LFCM Holdings LLC. | Analyst-Equity | 31.01.2014 |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Analyst-Equity | - |
Ausbildung von Ryan Martins
Virginia Polytechnic Institute & State University | Graduate Degree |
University of Mumbai | Graduate Degree |
Haas School of Business | Masters Business Admin |
St. Xavier's College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ULTRAGENYX PHARMACEUTICAL INC. | Health Technology |
89BIO, INC. | Health Technology |
REVOLUTION MEDICINES, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Lehman Brothers, Inc.
Lehman Brothers, Inc. Investment Banks/BrokersFinance A subsidiary of Lehman Brothers Holdings, Inc., Lehman Brothers, Inc. is a broker/dealer headquartered in New York City. They provide global equity and fixed research. The equity research department covers more than 100 sectors. They use a fundamental, quantitative, strategic and tactical research approach. In addition to these Lehman has also developed special products, such as 10 uncommon values and 10 uncommon eurovalues. | Finance |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance FM Partners Holdings LLC is a broker/dealer headquartered in New York City. The firm was formerly known as Lazard Capital Markets LLC.. They are a subsidiary of LFCM Holdings LLC. | Finance |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Jefferies LLC
Jefferies LLC Investment Banks/BrokersFinance Jefferies LLC is a global investment bank and institutional securities firm headquartered in New York City. The firm was founded in 1962 and is a subsidiary of Jefferies Group LLC, ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF). Jefferies provides corporate clients with research and execution services in equity, fixed income, and foreign exchange markets, as well as a full range of investment banking services such as underwriting, mergers and acquisitions, restructuring and recapitalization, and other advisory services, with all businesses operating in the Americas, Europe and Asia. | Finance |